2-氟-4-碘苯胺 、 1,2,3-三氟-5-(2-甲氧基乙氧基)-4-硝基苯 以to form the title compound (1.02 g, 32%)的产率得到2,3-difluoro-N-(2-fluoro-4-iodophenyl)-5-(2-methoxyethoxy)-6-nitroaniline
参考文献:
名称:
DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES INCLUDING POLYMORPHS AS INHIBITORS OF MEK AS WELL AS COMPOSITIONS, METHODS OF USE AND METHODS FOR PREPARING THE SAME
申请人:Vernier Jean-Michel
公开号:US20110060049A1
公开(公告)日:2011-03-10
This invention concerns N-(2-arylamino) aryl sulfonamide compounds which are inhibitors of MEK including crystalline polymorphic forms which exhibit a specific powder x-ray diffraction profile and/or a specific differential scanning calorimetry profile. This invention also concerns pharmaceutical compositions comprising the compounds described herein and methods of use of the compounds and compositions described herein, including the use in the treatment and/or prevention of cancer, hyperproliferative diseases and inflammatory conditions. The invention also concerns methods of making the compounds and compositions described herein.
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
申请人:Ardea Biosciences
公开号:US07759518B2
公开(公告)日:2010-07-20
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
DERIVATIVES OF N-(ARYLAMINO)SULFONAMIDES AS INHIBITORS OF MEK
申请人:MADERNA Andreas
公开号:US20120022076A1
公开(公告)日:2012-01-26
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
Compositions and methods for preparing and using same
申请人:Quart Barry D.
公开号:US08808742B2
公开(公告)日:2014-08-19
This invention relates to compositions, methods for preparing the compositions and methods for treating or preventing diseases, comprising administering the compositions.
本发明涉及组合物、制备组合物的方法以及治疗或预防疾病的方法,包括给予该组合物。
Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
申请人:Maderna Andreas
公开号:US08829052B2
公开(公告)日:2014-09-09
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.